|
1
|
Dubey AK, Gupta U and Jain S: Epidemiology
of lung cancer and approaches for its prediction: A systematic
review and analysis. Chin J Cancer. 35:712016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang D, Liu Y, Bai C, Wang X and Powell
CA: Epidemiology of lung cancer and lung cancer screening programs
in China and the United States. Cancer Lett. 468:82–87. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou J, Liu B, Li Z, Li Y, Chen X, Ma Y,
Yan S, Yang X, Zhong L and Wu N: Proteomic analyses identify
differentially expressed proteins and pathways between Low-risk and
High-risk subtypes of Early-stage lung adenocarcinoma and their
prognostic impacts. Mol Cell Proteomics. 20:1000152021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Röhrig F and Schulze A: The multifaceted
roles of fatty acid synthesis in cancer. Nat Rev Cancer.
16:732–749. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Santos CR and Schulze A: Lipid metabolism
in cancer. FEBS J. 279:2610–2623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Winkelkotte AM, Al-Shami K, Chaves-Filho
AB, Vogel FCE and Schulze A: Interactions of fatty acid and
cholesterol metabolism with cellular stress response pathways in
cancer. Cold Spring Harb Perspect Med. 15:a0415482025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Angeles-Lopez QD, Rodriguez-Lopez J,
Agudelo Garcia P, Calyeca J, Álvarez D, Bueno M, Tu LN,
Salazar-Terreros M, Vanegas-Avendaño N, Krull JE, et al: Regulation
of lung progenitor plasticity and repair by fatty acid oxidation.
JCI Insight. 10:e1658372025. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Liu X, Liu Y, Yan F, Zeng Y, Song
Y, Fang H, Song D and Wang X: Lysophosphatidylcholine inhibits lung
cancer cell proliferation by regulating fatty acid metabolism
enzyme long-chain acyl-coenzyme A synthase 5. Clin Transl Med.
13:e11802023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Z, Gong Y, Chen F, Lee HJ, Qian J,
Zhao J, Zhang W, Li Y, Zhou Y, Xu Q, et al: Orchestrated
desaturation reprogramming from stearoyl-CoA desaturase to fatty
acid desaturase 2 in cancer epithelial-mesenchymal transition and
metastasis. Cancer Commun (Lond). 45:245–280. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li H, Sun J, Hu H and Wang Y:
Transcription factor E2F8 activates PDK1-Mediated DNA damage repair
to enhance cisplatin resistance in lung adenocarcinoma.
Pharmacology. 109:341–356. 2024.PubMed/NCBI
|
|
11
|
Chen J, Alduais Y, Zhang K, Zhu X and Chen
B: CCAT1/FABP5 promotes tumour progression through mediating fatty
acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung
adenocarcinoma. J Cell Mol Med. 25:9199–9213. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Z, Hu Z, Sui Q, Huang Y, Zhao M, Li
M, Liang J, Lu T, Zhan C, Lin Z, et al: LncRNA FAM83A-AS1
facilitates tumor proliferation and the migration via the
HIF-1α/glycolysis axis in lung adenocarcinoma. Int J Biol Sci.
18:522–535. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Binnewies M, Roberts EW, Kersten K, Chan
V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI,
Ostrand-Rosenberg S, Hedrick CC, et al: Understanding the tumor
immune microenvironment (TIME) for effective therapy. Nat Med.
24:541–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo Y, Wang H, Liu B and Wei J: Fatty acid
metabolism and cancer immunotherapy. Curr Oncol Rep. 24:659–670.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tomida S, Takeuchi T, Shimada Y, Arima C,
Matsuo K, Mitsudomi T, Yatabe Y and Takahashi T: Relapse-related
molecular signature in lung adenocarcinomas identifies patients
with dismal prognosis. J Clin Oncol. 27:2793–2799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Friedman J, Hastie T and Tibshirani R:
Regularization paths for generalized linear models via coordinate
descent. J Stat Softw. 33:1–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee BK, Mayhew EJ, Sanchez-Lengeling B,
Wei JN, Qian WW, Little KA, Andres M, Nguyen BB, Moloy T, Yasonik
J, et al: A principal odor map unifies diverse tasks in olfactory
perception. Science. 381:999–1006. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Helmreich JE: Regression modeling
strategies with applications to linear models, logistic and ordinal
regression and survival analysis (2nd edition). J Statistical
Software Book Rev. 70:1–3. 2016.
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koundouros N and Poulogiannis G:
Reprogramming of fatty acid metabolism in cancer. Br J Cancer.
122:4–22. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eltayeb K, La Monica S, Tiseo M, Alfieri R
and Fumarola C: Reprogramming of lipid metabolism in lung cancer:
An overview with focus on EGFR-Mutated Non-small cell lung cancer.
Cells. 11:4132022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Petiti J, Arpinati L, Menga A and Carrà G:
The influence of fatty acid metabolism on T cell function in lung
cancer. FEBS J. 292:3596–3615. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu S, Pan X, Volckova E, Shinde A, Fuller
SR, Egan R, Ma J, Kung J, Ott CJ, Hata AN, et al: Targeting
monounsaturated fatty acid metabolism for radiosensitization of
KRAS mutant 3D lung cancer models. Mol Cancer Ther. 24:920–930.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Relat J, Blancafort A, Oliveras G, Cufí S,
Haro D, Marrero PF and Puig T: Different fatty acid metabolism
effects of (−)-epigallocatechin-3-gallate and C75 in adenocarcinoma
lung cancer. BMC Cancer. 12:2802012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang D, Tang E, Zhang T and Xu G:
Characteristics of fatty acid metabolism in lung adenocarcinoma to
guide clinical treatment. Front Immunol. 13:9162842022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang X, Li J, Pang H, Zheng H, Shi X, Feng
L, Hu K and Zhou T: Xingxiao pills suppresses lung adenocarcinoma
progression by modulating lipid metabolism and inhibiting the
PLA2G4A-GLI1-SOX2 Axis. Phytomedicine. 143:1568262025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Song Y, Shi Q and Fu L: Research
progress on FASN and MGLL in the regulation of abnormal lipid
metabolism and the relationship between tumor invasion and
metastasis. Front Med. 15:649–656. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ali A, Levantini E, Teo JT, Goggi J,
Clohessy JG, Wu CS, Chen L, Yang H, Krishnan I, Kocher O, et al:
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated
non-small cell lung cancer. EMBO Mol Med. 10:e83132018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vitale I, Manic G, Coussens LM, Kroemer G
and Galluzzi L: Macrophages and metabolism in the tumor
microenvironment. Cell Metab. 30:36–50. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu L, Zhang X, Zheng L, Zhao H, Yan G,
Zhang Q, Zhou Y, Lei J, Zhang J, Wang J, et al: RIPK3 orchestrates
fatty acid metabolism in Tumor-associated macrophages and
hepatocarcinogenesis. Cancer Immunol Res. 8:710–721. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen Y, Zhou Y, Ren R, Chen Y, Lei J and
Li Y: Harnessing lipid metabolism modulation for improved
immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer.
12:e0088112024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu M, Zeng Q, Fan T, Lei Y, Wang F, Zheng
S, Wang X, Zeng H, Tan F, Sun N, et al: Clinical significance and
immunometabolism landscapes of a novel Recurrence-associated lipid
metabolism signature in Early-stage lung adenocarcinoma: A
comprehensive analysis. Front Immunol. 13:7834952022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kanno T, Nakajima T, Kawashima Y, Yokoyama
S, Asou HK, Sasamoto S, Hayashizaki K, Kinjo Y, Ohara O, Nakayama T
and Endo Y: Acsbg1-dependent mitochondrial fitness is a metabolic
checkpoint for tissue Treg cell homeostasis. Cell Rep.
37:1099212021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maguire OA, Ackerman SE, Szwed SK, Maganti
AV, Marchildon F, Huang X, Kramer DJ, Rosas-Villegas A, Gelfer RG,
Turner LE, et al: Creatine-mediated crosstalk between adipocytes
and cancer cells regulates obesity-driven breast cancer. Cell
Metab. 33:499–512.e6. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou S, Sung E, Prakosa A, Aronis KN,
Chrispin J, Tandri H, AbdelWahab A, Horáček BM, Sapp JL and
Trayanova NA: Feasibility study shows concordance between
image-based virtual-heart ablation targets and predicted ECG-based
arrhythmia exit-sites. Pacing Clin Electrophysiol. 44:432–441.
2021. View Article : Google Scholar : PubMed/NCBI
|
